Literature DB >> 11103152

Gastric stromal tumours: a practical approach.

N Mihssin1, K Moorthy, A Sengupta, P W Houghton.   

Abstract

Recent findings on the pathological diversity of gastric stromal tumours and their unpredictable behaviour prompted us to review our series of 16 patients who had undergone surgery for these tumours from 1991 to 1998. There were 13 benign and 3 malignant lesions. The majority of patients presented with either upper gastrointestinal bleeding or anaemia alone (12 of 16). Endoscopy was an extremely useful diagnostic tool, revealing the lesion as an intraluminal protuberant tumour with or without ulcer in 10 cases and as an ulcer alone in 4 cases, and in 1 case features suggesting an extrinsic mass. All the patients in the series underwent surgery. We used staplers (AutosutureR TA 55) to excise the tumours in 7 cases, all of which on histological examination were benign with clear resection margins. Gastric resections were performed in 5 cases for either large tumours or those situated at the fundus or antrum and local excision of the remaining 4. The mean follow-up of these patients was 24 months. Two patients with malignant lesions died of irresectable recurrences, one 2 months and one 18 months after surgery. There have been no recurrences in the tumours diagnosed as benign on histology. Tumour size, position and the ability to apply the stapler leaving adequate margin below the tumour should be the determinants of extent and type of excision. Reliable determinants of behaviour are tumour size, grade and mitotic index.

Entities:  

Mesh:

Year:  2000        PMID: 11103152      PMCID: PMC2503480     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  17 in total

Review 1.  Mesenchymal tumors of the gut: historical perspectives, new approaches, new results, and does it make any difference?

Authors:  H D Appelman
Journal:  Monogr Pathol       Date:  1990

2.  Gastrointestinal stromal tumor of the stomach.

Authors:  T Ishii; Y Kuyama; M Obara; M Yamanaka; T Imamura
Journal:  Intern Med       Date:  1997-06       Impact factor: 1.271

3.  Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years.

Authors:  H L Evans
Journal:  Cancer       Date:  1985-11-01       Impact factor: 6.860

4.  Cellular leiomyomas of the stomach in 49 patients.

Authors:  H Appelman; E B Helwig
Journal:  Arch Pathol Lab Med       Date:  1977-07       Impact factor: 5.534

5.  Gastric stromal tumors. Reappraisal of histogenesis.

Authors:  M T Mazur; H B Clark
Journal:  Am J Surg Pathol       Date:  1983-09       Impact factor: 6.394

6.  A flow cytometric, clinical, and histological study of stromal neoplasms of the gastrointestinal tract.

Authors:  P N Cooper; P Quirke; G J Hardy; M F Dixon
Journal:  Am J Surg Pathol       Date:  1992-02       Impact factor: 6.394

7.  Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging.

Authors:  E H Ng; R E Pollock; M F Munsell; E N Atkinson; M M Romsdahl
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

8.  Leiomyosarcoma of the stomach: determinants of long-term survival.

Authors:  G Farrugia; C H Kim; C S Grant; A R Zinsmeister
Journal:  Mayo Clin Proc       Date:  1992-06       Impact factor: 7.616

9.  Cell markers in gastrointestinal stromal tumors.

Authors:  A M Pike; R V Lloyd; H D Appelman
Journal:  Hum Pathol       Date:  1988-07       Impact factor: 3.466

Review 10.  Current clinical and pathologic perspectives on gastric stromal tumors.

Authors:  M D Basson; I M Modlin; S D Flynn
Journal:  Surg Gynecol Obstet       Date:  1992-11
View more
  1 in total

1.  Gastrointestinal bleeding due to suspected anisakiasis: challenging differential diagnosis for a rare disease.

Authors:  Marco Filauro; Gian Andrea Rollandi; Giovanni Cassola; Paolo Quilici; Giulio Angelini; Fiorenza Belli; Chiara Boccardo
Journal:  Updates Surg       Date:  2011-03-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.